The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI
- Conditions
- Infertility
- Registration Number
- NCT01594645
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
Presently spermatozoa for ICSI are selected based on morphology and motion, without determining if acrosome reaction (AR) had occurred during sperm preparation or not. Although not critical if the sperm is injected into the ooplasm, the occurrence of AR might might be an indicator of better spermatozoon quality and implantation potential, especially in severe OTA cases. It is impossible with conventional plain optic microscopy used in IVF units to determine in vivo (without fixation) if AR has occurred, and as a result spermatozoa are injected randomly. It is readily possible to distinguish AR+ from AR- spermatozoa using polarized light microscopy due to different bifriengance.
In this study the investigators seek to determine, by a prospective RCT, if selecting only acrosome reacted spermatozoa, in severe OTA cases, will improve the outcome of ICSI and the entire IVF process.
- Detailed Description
A prospective RCT to determine the effect of polscope based spermatozoa selection for ICSI.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Female: normal uterine cavity and ovarian reserve. Male: TMC < 1000000 cells.
- Female: Abnormal uterine anatomy, low ovarian reserve, contributing egg factor, PGD.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method fertilization rate 24-72 h Determine the impact of AR+ spermatozoa selection of fertilization and in vitro embryonic development.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy up to 6 weeks The occurrence of clinical pregnancies in both arms.
Trial Locations
- Locations (1)
Hadassah University Hospital
🇮🇱Jerusalem, Israel
Hadassah University Hospital🇮🇱Jerusalem, Israel